People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RareCyte, Inc. | — | Other | Series B | $79.8M | $103.6M | 2023 |
Stephen J. Reichenbach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen J. Reichenbach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew J. Schwab | 1 | 7 |
| Brian Daniels | 1 | 5 |
| Robert Shepler | 1 | 4 |
| Frank Witney | 1 | 3 |
| Joseph Victor | 1 | 2 |
| Frank J. Witney | 1 | 2 |
| Robert J. Weisskoff | 1 | 2 |
| Eric Kaldjian | 1 | 1 |
| Ronald Seubert | 1 | 1 |
| Evan Castiglia | 1 | 1 |
| David J. Kabakoff | 1 | 1 |
| Ronald J. Seubert | 1 | 1 |
| Daniel J. Marshak | 1 | 1 |
| Jan J. Garfinkle | 1 | 1 |
| Joseph J. Victor Jr. | 1 | 1 |
| Jim J. Cooper | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.